GCS - German Cannabis Standard

📍 Berlin, Germany🗓 Founded 2020👥 14 employees💰 Last funded May 2022
Pharmaceutical Manufacturing🌐 germancannabisstandard.de
Website LinkedIn
Our vertical integrated ecosystem makes GCS the Gatekeeper in Germany * GCS Cultivation is building the largest German cultivation facility for medical cannabis to provide high quality strains, “Made‑in‑Germany”, to pharmacies that outperforms on freshness & consistency * Blütezeit is our own telemedicine platform providing legal and compliant access to medical cannabis by connecting doctors to patients. It serves as the patient-facing brand and primary patient gateway. * Cannaflow`s B2B software and marketplace empowers pharmacies to manage, distribute and connect cannabis via multiple channels, e.g. wholesale partners, telemedicine platforms and patients * Cannabiosan is our virtual wholesaler/GPO using an asset-light model to aggregate pharmacy demand and thus is key in the democratization process of pharmacies
6
Total investors
6
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
6
Frequently asked questions
Who invested in GCS - German Cannabis Standard?
GCS - German Cannabis Standard has 6 investors on record on gritt.io, including 6 early-stage backers.
When did GCS - German Cannabis Standard last raise funding?
The most recent investment in GCS - German Cannabis Standard recorded on gritt.io was in May 2022.
When was GCS - German Cannabis Standard founded?
GCS - German Cannabis Standard was founded in 2020.
What industry is GCS - German Cannabis Standard in?
GCS - German Cannabis Standard operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is GCS - German Cannabis Standard based?
GCS - German Cannabis Standard is headquartered in Berlin, Germany.